Skip to content

Prospective Cohort Follow-up of French Patients With Profound and Multiple Disabilities: Healthcare Pathways and Quality of Life Among Patients and Their Families

Prospective Cohort Follow-up of French Patients With Profound and Multiple Disabilities: Healthcare Pathways and Quality of Life Among Patients and Their Families

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02400528
Acronym
Eval-PLH
Enrollment
1200
Registered
2015-03-27
Start date
2015-02-28
Completion date
2019-02-28
Last updated
2015-03-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ataxia, Extrapyramidal Motor Disorders, Hemiparesis, Neuromuscular Disorders, Paraparesis, Tetraparesis

Brief summary

The studies conducted so far concerning the medical and paramedical cares provided to patients with profound and multiple disabilities (PMD) often show important limitations: samples are too small or very heterogeneous, generally constituted of children only; studies are mainly cross-sectional and retrospective, focusing on very specific issues instead of assessing health and quality of life from a more global perspective… So far, the investigators found no published data from a prospective cohort study involving a representative sample of patients with PMD. The present project aims to set up such a cohort so as to describe for the first time the natural history of French patients with PMD as well as the cares they receive at home or within the different dedicated structures in France. This cohort will also make it possible to identify the factors responsible for differences in the cares patients are provided, the consequences of these differences on their health and their quality of life (and those of their relatives) as well as the evolutions of these data over time. It will then allow for assessing the effectiveness of the French healthcare system to care for patients with PMD as well as building a frame of reference regarding the best cares to provide to these patients. The primary goal of this study is to identify the determinants of health among patients with PMD.

Interventions

BEHAVIORALquality of life questionnaires

Sponsors

Assistance Publique Hopitaux De Marseille
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
3 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* age \> 3 years old, * patient with health insurance, * causal brain injury before the age of 3, * Intellectual Quotient \< 40 or not assessable, * motor disability: paraparesis, tetraparesis, hemiparesis, ataxia, neuromuscular disorders, or extrapyramidal motor disorders, * score at the Gross Motor Function Classification System \> 3, * score at the Functional Independence Measure \< 55.

Exclusion criteria

Subject declaring benefit psychotropic treatment which significantly alter the reasoning, discernment or judgment.

Design outcomes

Primary

MeasureTime frameDescription
Caregivers quality of life36 monthsAssessment of quality of life from questionnaires,WHOQOL-Bref, Brief-COPE \- Brief-COPE

Secondary

MeasureTime frameDescription
emotional distress and subjective burden of natural caregivers,36 monthsAssessment of quality of life from questionnaires,WHOQOL-Bref * Brief-COPE * CRA
burnout of institutional caregivers36 monthsAssessment of quality of life from questionnaires,WHOQOL-Bref * Brief-COPE * MBI

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 5, 2026